{"id":959739,"date":"2026-05-07T08:19:25","date_gmt":"2026-05-07T12:19:25","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/"},"modified":"2026-05-07T08:19:25","modified_gmt":"2026-05-07T12:19:25","slug":"urogen-pharma-to-present-at-upcoming-investor-conferences-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/","title":{"rendered":"UroGen Pharma to Present at Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">PRINCETON, N.J., May  07, 2026  (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May.<\/p>\n<table style=\"border-collapse: collapse;margin-left:0px;margin-right:auto;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"padding-left: 0;padding-right: 0;vertical-align: middle\">\n            <strong>Bank of America Health Care Conference 2026<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Date \/ Time:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: middle\">May 13th, at 11:15 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Format:<\/td>\n<td style=\"vertical-align: middle\">1&#215;1\u2019s<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Location:<\/td>\n<td style=\"vertical-align: middle\">Las Vegas, NV<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Webcast Link:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/bofa.veracast.com\/webcasts\/bofa\/healthcare2026\/id61043R.cfm\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <u>Here<\/u><br \/>\n            <\/a><br \/>\n            \n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;margin-left:0px;margin-right:auto;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"padding-left: 0;padding-right: 0;vertical-align: middle\">\n            <strong>HC Wainwright 4<\/strong><br \/>\n            <sup><br \/>\n              <strong>th<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> Annual BioConnect Investor Conference<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Date \/ Time:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: middle\">May 19th, at 10:30 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Format:<\/td>\n<td style=\"vertical-align: middle\">1&#215;1\u2019s<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Location:<\/td>\n<td style=\"vertical-align: middle\">New York, NY<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Webcast Link:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/journey.ct.events\/view\/461410d4-c1ae-4b54-8feb-b7c307534488\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <u>Here<\/u><br \/>\n            <\/a><br \/>\n            \n          <\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table style=\"border-collapse: collapse;margin-left:0px;margin-right:auto;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"padding-left: 0;padding-right: 0;vertical-align: middle\">\n            <strong>TD Cowen 7<\/strong><br \/>\n            <sup><br \/>\n              <strong>th<\/strong><br \/>\n            <\/sup><br \/>\n            <strong> Annual Oncology Innovation Summit<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Date \/ Time:<\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;vertical-align: middle\">May 26th, at 10:30 AM ET<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Location:<\/td>\n<td style=\"vertical-align: middle\">Virtual<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: middle;text-align: left;padding-left: 10.0px;vertical-align: middle\">Webcast Link:<\/td>\n<td style=\"vertical-align: middle\">\n            <a href=\"https:\/\/event.summitcast.com\/view\/kfuZxTU367tCYbuZzaSD2X\/4DgvmLqsugzhCmb4wezMUJ\" rel=\"nofollow\" target=\"_blank\"><br \/>\n              <u>Here<\/u><br \/>\n            <\/a><br \/>\n            \n          <\/td>\n<\/tr>\n<tr>\n<td colspan=\"2\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p align=\"left\">The webcasts from the conference will also be available on UroGen\u2019s Investor Relations <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9fdPGSI_RGb5ztXMJEzkCR8_XW-e1VnB-TI5kGs-wculMC9uOR5NAKzNI4Jen9MYODCLrMZq1KbLHFd8_W2pjA2VVSi6N_DR0U1xPIakJnNWDA0geeTEWirA9VEwK02K\" rel=\"nofollow\" target=\"_blank\"><u>website<\/u><\/a>. A replay will be available for approximately 90 days.<\/p>\n<p align=\"left\">\n        <strong>About UroGen Pharma Ltd.<\/strong>\n      <\/p>\n<p align=\"left\">UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed RTGel\u00ae reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. UroGen\u2019s first product to treat LG-UTUC and second product (mitomycin) for intravesical solution for adults with recurrent LG-IR-NMIBC are designed to ablate tumors by non-surgical means. UroGen is headquartered in Princeton, NJ with operations in Israel. Visit www.urogen.com to learn more or follow us on X, @UroGenPharma.<\/p>\n<p align=\"left\">INVESTORS:<\/p>\n<p align=\"left\">Vincent Perrone<br \/>Senior Director, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=olKJJm8GgtI8tJ6rRTt4WsuZSgUoYxZZF2p0N6C1kaGdxvDROapZxzU5jT_FhK-Xs8kK6j6bNWsE7WX28SWrzEvVYA7jLwt9VYNg0NLdQaxWse7A6Fj_ZCQBULjA1Dj4\" rel=\"nofollow\" target=\"_blank\"><u>vincent.perrone@urogen.com<\/u><\/a><br \/>609-460-3588 ext. 1093<\/p>\n<p align=\"left\">MEDIA:<\/p>\n<p align=\"left\">Cindy Romano<br \/>Director, Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l8qeToPT3-r67BcwsQX-qQUhsjaQiyOJ_94ymZstTFCDHmgoHyv-hVbzHMBVC1JFfwtclI_QbwMvC5cWbXP04EgWHe9QMWzFHnSsHty3r8yuQGg9TDpMHtOgOu4C8Hzs\" rel=\"nofollow\" target=\"_blank\"><u>cindy.romano@urogen.com<\/u><\/a><br \/>609-460-3566 ext. 1083<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTYxMWZiM2ItMDE0NS00Njg5LThmYzQtYWYyNGM0MjI3YzExLTEwNDA1OTAtMjAyNi0wNS0wNy1lbg==\/tiny\/UroGen-Pharma-Ltd-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May. Bank of America Health Care Conference 2026 Date \/ Time: May 13th, at 11:15 AM ET Format: 1&#215;1\u2019s Location: Las Vegas, NV Webcast Link: Here HC Wainwright 4 th Annual BioConnect Investor Conference Date \/ Time: May 19th, at 10:30 AM ET Format: 1&#215;1\u2019s Location: New York, NY Webcast Link: Here TD Cowen 7 th Annual Oncology Innovation Summit Date \/ Time: May 26th, at 10:30 AM ET Location: Virtual Webcast Link: Here \u00a0 The webcasts from the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;UroGen Pharma to Present at Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-959739","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May. Bank of America Health Care Conference 2026 Date \/ Time: May 13th, at 11:15 AM ET Format: 1&#215;1\u2019s Location: Las Vegas, NV Webcast Link: Here HC Wainwright 4 th Annual BioConnect Investor Conference Date \/ Time: May 19th, at 10:30 AM ET Format: 1&#215;1\u2019s Location: New York, NY Webcast Link: Here TD Cowen 7 th Annual Oncology Innovation Summit Date \/ Time: May 26th, at 10:30 AM ET Location: Virtual Webcast Link: Here \u00a0 The webcasts from the &hellip; Continue reading &quot;UroGen Pharma to Present at Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T12:19:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UroGen Pharma to Present at Upcoming Investor Conferences\",\"datePublished\":\"2026-05-07T12:19:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/\"},\"wordCount\":291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/\",\"name\":\"UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\",\"datePublished\":\"2026-05-07T12:19:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Pharma to Present at Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk","og_description":"PRINCETON, N.J., May 07, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it will participate in the following investor conferences in May. Bank of America Health Care Conference 2026 Date \/ Time: May 13th, at 11:15 AM ET Format: 1&#215;1\u2019s Location: Las Vegas, NV Webcast Link: Here HC Wainwright 4 th Annual BioConnect Investor Conference Date \/ Time: May 19th, at 10:30 AM ET Format: 1&#215;1\u2019s Location: New York, NY Webcast Link: Here TD Cowen 7 th Annual Oncology Innovation Summit Date \/ Time: May 26th, at 10:30 AM ET Location: Virtual Webcast Link: Here \u00a0 The webcasts from the &hellip; Continue reading \"UroGen Pharma to Present at Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/","og_site_name":"Market Newsdesk","article_published_time":"2026-05-07T12:19:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UroGen Pharma to Present at Upcoming Investor Conferences","datePublished":"2026-05-07T12:19:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/"},"wordCount":291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/","name":"UroGen Pharma to Present at Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=","datePublished":"2026-05-07T12:19:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcxNTE3OCM3NTg4Mzk0IzIwMjkwMTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/urogen-pharma-to-present-at-upcoming-investor-conferences-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UroGen Pharma to Present at Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/959739","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=959739"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/959739\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=959739"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=959739"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=959739"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}